Propranolol versus Other Selected Drugs in the Treatment of Various Types of Anxiety or Stress, with Particular Reference to Stage Fright and Post-Traumatic Stress Disorder
Open accessThe DOI matches its Crossref record; 194 of the 195 references it cites were found in a registry or an index.
Abstract
Propranolol, a non-cardioselective β1,2 blocker, is most commonly recognised for its application in the therapy of various cardiovascular conditions, such as hypertension, coronary artery disease, and tachyarrhythmias. However, due to its ability to cross the blood–brain barrier and affinity towards multiple macromolecules, not only adrenoreceptors, it has also found application in other fields. For example, it is one of the very few medications successfully applied in the treatment of stage fright. This review focuses on the application of propranolol in the treatment of various types of anxiety and stress, with particular reference to stage fright and post-traumatic stress disorder (PTSD). Both mechanisms of action as well as comparison with other therapies are presented. As those indications for propranolol are, in most countries, considered off-label, this review aims to gather information that can be useful while making a decision about the choice of propranolol as a drug in the treatment of those mental conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The Trier Social Stress Test (TSST) is regarded as the gold standard in simulating a stressful social situation”
From Efficacy and safety of an alpha 7-nicotinic acetylcholine receptor agonist, VQW-765, in subjects with performance anxiety: randomised, double-blind, placebo-controlled trial (2025) · cites this paper as [10]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Rayyan-a web and mobile app for systematic reviews.
Ouzzani, M., Hammady, H., Fedorowicz, Z., & Elmagarmid, A. (2016) · Systematic Reviews · doi:10.1186/s13643-016-0384-4 · Cited by 26,092
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · Systematic Reviews · doi:10.1186/s13643-021-01626-4 · Cited by 13,874 · cited 1×
“The present review was performed according to the Preferred Reporting Items for Systematic Reviews (PRISMA) statement (Figure 3) [193], and it was registered in the Open Science Framework (OSF) (registration: https://doi.”
MethodThe PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · International Journal of Surgery · doi:10.1016/j.ijsu.2021.105906 · Cited by 11,748
Posttraumatic Stress Disorder in the National Comorbidity Survey
Kessler, R. C. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240066012 · Cited by 10,379 · cited 2×
“However, at least a third of those who initially develop PTSD continue to face symptoms for three years or longer [21].”
BackgroundThe PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J., Bossuyt, P., Boutron, I., Hoffmann, T., mulrow, C., Shamseer, L., Tetzlaff, J., Akl, E., Brennan, S. E., et al. (2020) · doi:10.31222/osf.io/v7gm2_v1 · Cited by 8,090
Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval
Nader, K., Schafe, G. E., & Le Doux, J. E. (2000) · Nature · doi:10.1038/35021052 · Cited by 2,706 · cited 2×
“Fear memory reconsolidation is the process by which reactivation by exposure to the conditioned stimulus (CS) or an unconditioned stimulus (US) makes memory traces labile, thereby triggering transient protein destabilisation that can be modified by pharmacological and behavioural interventions for several hours after…”
BackgroundTolin, D. F., & Foa, E. B. (2006) · Psychological Bulletin · doi:10.1037/0033-2909.132.6.959 · Cited by 2,197 · cited 1×
“Females are more than twice as likely as males to develop PTSD following a traumatic event [32].”
BackgroundThe global burden of mental disorders: An update from the WHO World Mental Health (WMH) surveys
Kessler, R. C., Aguilar-Gaxiola, S., Alonso, J., Chatterji, S., Lee, S., Ormel, J., Üstün, T. B., & Wang, P. S. (2009) · Epidemiologia e Psichiatria Sociale · doi:10.1017/s1121189x00001421 · Cited by 1,895 · cited 1×
“The majority of mental health disorders are anxiety-related [84], and they have significant psychological, social, and financial implications [85].”
BackgroundBiological studies of post-traumatic stress disorder
Pitman, R. K., Rasmusson, A. M., Koenen, K. C., Shin, L. M., Orr, S. P., Gilbertson, M. W., Milad, M. R., & Liberzon, I. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3339 · Cited by 1,529
β-Adrenergic activation and memory for emotional events
Cahill, L., Prins, B., Weber, M., & McGaugh, J. L. (1994) · Nature · doi:10.1038/371702a0 · Cited by 1,271
Preventing the return of fear in humans using reconsolidation update mechanisms
Schiller, D., Monfils, M.-H., Raio, C. M., Johnson, D. C., LeDoux, J. E., & Phelps, E. A. (2010) · Nature · doi:10.1038/nature08637 · Cited by 1,248
Dissociable stages of human memory consolidation and reconsolidation
Walker, M. P., Brakefield, T., Allan Hobson, J., & Stickgold, R. (2003) · Nature · doi:10.1038/nature01930 · Cited by 1,025
Molecular mechanisms of fear learning and memory
Johansen, J. P., Cain, C. K., Ostroff, L. E., & LeDoux, J. E. (2011) · Cell · doi:10.1016/j.cell.2011.10.009 · Cited by 1,012
Pilot study of secondary prevention of posttraumatic stress disorder with propranolol
Pitman, R. K., Sanders, K. M., Zusman, R. M., Healy, A. R., Cheema, F., Lasko, N. B., Cahill, L., & Orr, S. P. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01279-3 · Cited by 964 · cited 2×
“Propranolol administered within the first 6 h after a traumatic event significantly reduces the likelihood of developing PTSD [59,60].”
BackgroundThe molecular biology of memory: cAMP, PKA, CRE, CREB-1, CREB-2, and CPEB
Kandel, E. R. (2012) · Molecular Brain · doi:10.1186/1756-6606-5-14 · Cited by 902
Spatial learning with a minislab in the dorsal hippocampus.
Moser, M. B., Moser, E. I., Forrest, E., Andersen, P., & Morris, R. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9697 · Cited by 898 · cited 1×
“The dorsal HPC (dHPC) is essential for learning and memory associated with exploration and spatial navigation [157].”
BackgroundBeyond extinction: erasing human fear responses and preventing the return of fear
Kindt, M., Soeter, M., & Vervliet, B. (2009) · Nature Neuroscience · doi:10.1038/nn.2271 · Cited by 826
Brady, K., Pearlstein, T., Asnis, G. M., Baker, D., Rothbaum, B., Sikes, C. R., & Farfel, G. M. (2000) · JAMA · doi:10.1001/jama.283.14.1837 · Cited by 690
Posttraumatic stress disorder: a state-of-the-science review
Nemeroff, C. B., Bremner, J. D., Foa, E. B., Mayberg, H. S., North, C. S., & Stein, M. B. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.07.005 · Cited by 675
Intrusive re‐experiencing in post‐traumatic stress disorder: Phenomenology, theory, and therapy
Ehlers, A., Hackmann, A., & Michael, T. (2004) · Memory · doi:10.1080/09658210444000025 · Cited by 645
Raskind, M. A., Peskind, E. R., Kanter, E. D., Petrie, E. C., Radant, A., Thompson, C. E., Dobie, D. J., Hoff, D., Rein, R. J., Straits-Tröster, K., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.371 · Cited by 607
Beddington, J., Cooper, C. L., Field, J., Goswami, U., Huppert, F. A., Jenkins, R., Jones, H. S., Kirkwood, T. B. L., Sahakian, B. J., & Thomas, S. M. (2008) · Nature · doi:10.1038/4551057a · Cited by 554 · cited 1×
“The majority of mental health disorders are anxiety-related [84], and they have significant psychological, social, and financial implications [85].”
BackgroundBrunet, A., Orr, S. P., Tremblay, J., Robertson, K., Nader, K., & Pitman, R. K. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.05.006 · Cited by 548
Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma
Vaiva, G., Ducrocq, F., Jezequel, K., Averland, B., Lestavel, P., Brunet, A., & Marmar, C. R. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00412-8 · Cited by 499 · cited 2×
“Moreover, administering propranolol three times per day for a week after a trauma minimised the onset of PTSD symptoms [59].”
BackgroundVermetten, E., Vythilingam, M., Southwick, S. M., Charney, D. S., & Bremner, J. D. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00634-6 · Cited by 487 · cited 1×
“In an uncontrolled trial, paroxetine therapy improved verbal memory function in PTSD patients [167].”
BackgroundPrzybyslawski, J., Roullet, P., & Sara, S. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-15-06623.1999 · Cited by 464
CSF Norepinephrine Concentrations in Posttraumatic Stress Disorder
Geracioti, T. D., Baker, D. G., Ekhator, N. N., West, S. A., Hill, K. K., Bruce, A. B., Schmidt, D., Rounds-Kugler, B., Yehuda, R., Keck, P. E., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.8.1227 · Cited by 462
Efficacy and Safety of Paroxetine Treatment for Chronic PTSD: A Fixed-Dose, Placebo-Controlled Study
Marshall, R. D., Beebe, K. L., Oldham, M., & Zaninelli, R. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.1982 · Cited by 432 · cited 2×
“The Food and Drug Administration (FDA) has approved only two medications to treat it (paroxetine hydrochloride and sertraline hydrochloride), both with limited efficacy [30,31].”
BackgroundTreatment of Hypertension with Propranolol
Prichard, B. N. C., & Gillam, P. M. S. (1969) · BMJ · doi:10.1136/bmj.1.5635.7 · Cited by 427
Phobias and preparedness: the selective, automatic, and encapsulated nature of fear
Mineka, S., & Öhman, A. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01669-4 · Cited by 414
The nature of intrusive memories after trauma: the warning signal hypothesis
Ehlers, A., Hackmann, A., Steil, R., Clohessy, S., Wenninger, K., & Winter, H. (2002) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(01)00077-8 · Cited by 392
Characterization of fear memory reconsolidation
Duvarci, S., & Nader, K. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2971-04.2004 · Cited by 379
Relationship Between Acute Morphine and the Course of PTSD in Children With Burns
SAXE, G., STODDARD, F., COURTNEY, D., CUNNINGHAM, K., CHAWLA, N., SHERIDAN, R., KING, D., & KING, L. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200108000-00013 · Cited by 344 · cited 1×
“According to paediatric studies, children with burns who do not receive adequate pain management may develop PTSD [25,26].”
BackgroundBrunet, A., Poundja, J., Tremblay, J., Bui, É., Thomas, É., Orr, S. P., Azzoug, A., Birmes, P., & Pitman, R. K. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318222f360 · Cited by 331
Intrusive memories in depression and posttraumatic stress disorder
Reynolds, M., & Brewin, C. R. (1999) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(98)00132-6 · Cited by 329
Urinary Catecholamine Excretion and Severity of PTSD Symptoms in Vietnam Combat Veterans
YEHUDA, R., SOUTHWICK, S., GILLER, E. L., XIAOWAN, &., & MASON, J. W. (1992) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199205000-00006 · Cited by 310
Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder
Strawn, J. R., & Geracioti, T. D. (2008) · Depression and Anxiety · doi:10.1002/da.20292 · Cited by 310 · cited 2×
“The hypernoradrenergic state is associated with the pathophysiology of PTSD [34].”
BackgroundSustained urinary norepinephrine and epinephrine elevation in post-traumatic stress disorder
Kosten, T. R., Mason, J. W., Giller, E. L., Ostroff, R. B., & Harkness, L. (1987) · Psychoneuroendocrinology · doi:10.1016/0306-4530(87)90017-5 · Cited by 308
Prediction Error Governs Pharmacologically Induced Amnesia for Learned Fear
Sevenster, D., Beckers, T., & Kindt, M. (2013) · Science · doi:10.1126/science.1231357 · Cited by 305
Zoladz, P. R., & Diamond, D. M. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.03.024 · Cited by 305
Propranolol Treatment for Childhood Posttraumatic Stress Disorder, Acute Type: A Pilot Study
Famularo, R. (1988) · American Journal of Diseases of Children · doi:10.1001/archpedi.1988.02150110122036 · Cited by 296
THE EFFECT OF PROPRANOLOL ON THE ANXIETY
Granville-Grossman, K. L., & Turner, P. (1966) · The Lancet · doi:10.1016/s0140-6736(66)91863-0 · Cited by 295 · cited 1×
“According to Granville-Grossman and Turner’s [87] cross-over study, patients with anxiety states were evaluated to be significantly better after two weeks of propranolol treatment compared to two weeks of placebo.”
MethodDissociating response systems: Erasing fear from memory
Soeter, M., & Kindt, M. (2010) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2010.03.004 · Cited by 290
Panagioti, M., Gooding, P. A., & Tarrier, N. (2012) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2012.02.009 · Cited by 280 · cited 1×
“This disorder has been linked to an increase in the frequency of suicide behaviours, such as suicidal thoughts, plans, or actions, as well as other mood disorders and anxiety symptoms [23,24].”
BackgroundA psychophysiological study of Post Traumatic Stress Disorder in Vietnam veterans
Blanchard, E. B., Kolb, L. C., Pallmeyer, T. P., & Gerardi, R. J. (1982) · Psychiatric Quarterly · doi:10.1007/bf01064817 · Cited by 278 · cited 1×
“Furthermore, PTSD patients’ HR or blood pressure (BP) have increased in reaction to stressful signals, demonstrating conditioned fear responses [36,37].”
BackgroundBodie, G. D. (2010) · Communication Education · doi:10.1080/03634520903443849 · Cited by 268 · cited 1×
“It is one of the most widespread fears, and it can lead to missed educational, social, and professional opportunities [99].”
BackgroundKrystal, J. H., Davis, L. L., Neylan, T. C., A. Raskind, M., Schnurr, P. P., Stein, M. B., Vessicchio, J., Shiner, B., Gleason, T. D., & Huang, G. D. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.03.007 · Cited by 265
Disrupting reconsolidation: Pharmacological and behavioral manipulations
Soeter, M., & Kindt, M. (2011) · Learning & Memory · doi:10.1101/lm.2148511 · Cited by 262
Reduction of PTSD symptoms with pre-reactivation propranolol therapy: A randomized controlled trial
Brunet, A., Saumier, D., Liu, A., Streiner, D. L., Tremblay, J., & Pitman, R. K. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17050481 · Cited by 256 · cited 2×
“In a randomised clinical trial [65] with “pre-reactivation propranolol therapy”, PTSD participants (N = 60) who actively recalled their traumatic event under the influence of propranolol once a week for up to six weeks showed a significant decrease in symptom scores (PTSD symptom improvement = 36%) compared to those w…”
BackgroundResultConceptually Driven Pharmacologic Approaches to Acute Trauma
Pitman, R. K., & Delahanty, D. L. (2005) · CNS Spectrums · doi:10.1017/s109285290001943x · Cited by 250 · cited 1×
“The AMG’s ability to activate and store memories is thought to be modulated by stress hormones, which propranolol is known to inhibit [152].”
BackgroundRetrieval per se is not sufficient to trigger reconsolidation of human fear memory
Sevenster, D., Beckers, T., & Kindt, M. (2012) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2012.01.009 · Cited by 238
Lonergan, M. H., Olivera-Figueroa, L. A., Pitman, R. K., & Brunet, A. (2013) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.120111 · Cited by 237 · cited 4×
“According to a meta-analysis, propranolol may be useful in the treatment of anxiety disorders caused by unsettling memories, notably PTSD [46].”
BackgroundInfluentialPropranolol for the treatment of anxiety disorders: Systematic review and meta-analysis
Steenen, S. A., van Wijk, A. J., van der Heijden, G. J., van Westrhenen, R., de Lange, J., & de Jongh, A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881115612236 · Cited by 237 · cited 5×
“It is classified as a competitive noncardioselective sympatholytic beta blocker that crosses the blood–brain barrier and, thus, exerts effects on the central nervous system, in addition to its peripheral activity [2].”
BackgroundInfluentialPosttraumatic stress symptoms of health care workers during the corona virus disease 2019
Yin, Q., Sun, Z., Liu, T., Ni, X., Deng, X., Jia, Y., Shang, Z., Zhou, Y., & Liu, W. (2020) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.2477 · Cited by 237 · cited 1×
“demics [11], are at risk of developing PTSD.”
BackgroundThe assessment and treatment of performance anxiety in musicians
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.5.598 · Cited by 235
An Abrupt Transformation of Phobic Behavior After a Post-Retrieval Amnesic Agent
Soeter, M., & Kindt, M. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.04.006 · Cited by 226
Dębiec, J., Bush, D. E. A., & LeDoux, J. E. (2011) · Depression and Anxiety · doi:10.1002/da.20803 · Cited by 223 · cited 1×
“The noradrenergic system is of key importance in modulating memory processes, and it has been found that stimulation of β-ARs facilitates the reconsolidation of emotional memory [146].”
BackgroundDȨBIEC, J., & LeDOUX, J. E. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1364.056 · Cited by 222
Nocturnal/daytime urine noradrenergic measures and sleep in combat-related PTSD
Mellman, T. A., Kumar, A., Kulick-Bell, R., Kumar, M., & Nolan, B. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00238-x · Cited by 219
Personality and stress in performing artists
Marchant-Haycox, S. E., & Wilson, G. D. (1992) · Personality and Individual Differences · doi:10.1016/0191-8869(92)90021-g · Cited by 209 · cited 1×
“Among performing artists, instrumentalists seem to be the most affected by anxiety, followed by singers, dancers, and actors [9].”
BackgroundPTSD symptoms and cognitive performance in recent trauma survivors
Brandes, D., Ben-Schachar, G., Gilboa, A., Bonne, O., Freedman, S., & Shalev, A. Y. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00125-7 · Cited by 205 · cited 1×
“Cognitive dysfunction has been identified in PTSD and linked to impaired traumatic memory processing [18], elevated psychiatric symptom severity, and functional disability [19].”
BackgroundClonidine in Cambodian Patients with Posttraumatic Stress Disorder
KINZIE, J. D., & LEUNG, P. (1989) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198909000-00005 · Cited by 196 · cited 1×
“Clonidine has been shown to alleviate nightmares and hyperarousal symptoms in patients with PTSD [172,176,183,184].”
BackgroundNeural Signature of Reconsolidation Impairments by Propranolol in Humans
Schwabe, L., Nader, K., Wolf, O. T., Beaudry, T., & Pruessner, J. C. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.10.028 · Cited by 182 · cited 1×
“Following memory reactivation, this API can decrease the identification of emotional pictures, according to additional research utilising functional magnetic resonance imaging [68].”
MethodInterleukin-6 production by astrocytes: Induction by the neurotransmitter norepinephrine
Gavin Norris, J., & Benveniste, E. N. (1993) · Journal of Neuroimmunology · doi:10.1016/0165-5728(93)90174-w · Cited by 180 · cited 1×
“Other research has connected NE (and propranolol) with IL-6 signalling, and one group suggested that infusion of the inflammatory cytokine IL-6 into the basolateral amygdala (BLA) in rats may alter fear extinction learning, possibly through the JAK/STAT3 pathway [140,141].”
BackgroundEffect of beta blockade and beta stimulation on stage fright.
Brantigan, C. O., Brantigan, T. A., & Joseph, N. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90592-7 · Cited by 178 · cited 10×
“The majority of the anxiolytic effect is produced by small doses of these drugs, since they are competitive inhibitors [48].”
BackgroundInfluentialHoge, E. A., Worthington, J. J., Nagurney, J. T., Chang, Y., Kay, E. B., Feterowski, C. M., Katzman, A. R., Goetz, J. M., Rosasco, M. L., Lasko, N. B., et al. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00227.x · Cited by 174 · cited 1×
“The physiological reactivity and HR of those who received propranolol 4–12 h after the trauma reportedly improved [64].”
BackgroundGREENDYKE, R. M., KANTER, D. R., SCHUSTER, D. B., VERSTREATE, S., & WOOTTON, J. (1986) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198605000-00005 · Cited by 172 · cited 1×
“When benzodiazepines, anticonvulsants, and major tranquillizers failed to manage adult patients’ explosive rage outbursts and episodic belligerence, propranolol was used successfully [108].”
BackgroundPerformance anxiety among professional musicians in symphonic orchestras: a self-report study
van Kemenade, J. F. L. M., van Son, M. J. M., & van Heesch, N. C. A. (1995) · Psychological Reports · doi:10.2466/pr0.1995.77.2.555 · Cited by 172
Elsesser, K., Sartory, G., & Tackenberg, A. (2004) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.113.2.289 · Cited by 166 · cited 1×
“Furthermore, PTSD patients’ HR or blood pressure (BP) have increased in reaction to stressful signals, demonstrating conditioned fear responses [36,37].”
BackgroundPathways to PTSD, Part I: Children With Burns
N. Saxe, G., Stoddard, F., Hall, E., Chawla, N., Lopez, C., Sheridan, R., King, D., King, L., & Yehuda, R. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.7.1299 · Cited by 165
EFFECT OF ADRENERGIC RECEPTOR BLOCKADE ON THE TACHYCARDIA OF THYROTOXICOSIS AND ANXIETY STATE
Turner, P., Granville-Grossman, K. L., & Smart, J. V. (1965) · The Lancet · doi:10.1016/s0140-6736(65)92340-8 · Cited by 162 · cited 1×
“This broad biological activity of propranolol explains why, soon after its discovery in the early 1960s, Turner and Granville-Grossman observed its anxiolytic effects [4].”
BackgroundPrediction error demarcates the transition from retrieval, to reconsolidation, to new learning
Sevenster, D., Beckers, T., & Kindt, M. (2014) · Learning & Memory · doi:10.1101/lm.035493.114 · Cited by 161
Propranolol: A 50-year historical perspective
Srinivasan, A. V. (2018) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_201_18 · Cited by 153 · cited 2×
“Propranolol (Figure 1), discovered by Nobel Prize laurate Sir James Black, was patented in 1962 and approved for medical use in 1964 [1].”
BackgroundAuxéméry, Y. (2012) · L Encéphale · doi:10.1016/j.encep.2011.12.003 · Cited by 148 · cited 1×
“It is believed that adrenaline helps memory consolidation and contributes to the reoccurrence of PTSD symptoms [35].”
BackgroundPharmacologic Reduction of CNS Noradrenergic Activity in PTSD: The Case for Clonidine and Prazosin
BOEHNLEIN, J. K., & KINZIE, J. D. (2007) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000265763.79753.c1 · Cited by 140 · cited 1×
“Clonidine has been shown to alleviate nightmares and hyperarousal symptoms in patients with PTSD [172,176,183,184].”
BackgroundEffect of Antihypertensive Agents on Quality of Life in the Elderly
Fogari, R., & Zoppi, A. (2004) · Drugs & Aging · doi:10.2165/00002512-200421060-00003 · Cited by 138 · cited 1×
“A common anxiolytic drug with minimal effects on cognition is propranolol hydrochloride [2,86].”
BackgroundRevisiting propranolol and PTSD: Memory erasure or extinction enhancement?
Giustino, T. F., Fitzgerald, P. J., & Maren, S. (2016) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2016.01.009 · Cited by 137 · cited 2×
“, those who would no longer benefit from acute propranolol paired with exposure therapy) [83].”
BackgroundAdamec, R. E., Muir, C. A., Grimes, M. T., & Pearcey, K. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.02.001 · Cited by 129
Propranolol for the control of belligerent behavior following acute brain damage
Elliott, F. A. (1977) · Annals of Neurology · doi:10.1002/ana.410010516 · Cited by 126 · cited 1×
“The use of this medicine has been documented in case reports for the treatment of agitation in organic patients [125], aggressive behaviour following acute brain damage [126], and postencephalitic psychosis [127].”
BackgroundEffects of the beta-blocker propranolol on cued and contextual fear conditioning in humans
Grillon, C., Cordova, J., Morgan, C. A., Charney, D. S., & Davis, M. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1819-5 · Cited by 122 · cited 1×
“Furthermore, propranolol is useful in lowering emotional arousal [47], eradicating stage fright [48], and alleviating anxiety-related cognitive dysfunction [49].”
BackgroundThe role of coping strategy and experience in predicting music performance anxiety
Biasutti, M., & Concina, E. (2014) · Musicae Scientiae · doi:10.1177/1029864914523282 · Cited by 121 · cited 1×
“Stage fright is a serious problem for many professional and amateur artists, as severe difficulties resulting from performance anxiety may lead to premature termination of promising careers [7,8].”
BackgroundSystemic Propranolol Acts Centrally to Reduce Conditioned Fear in Rats Without Impairing Extinction
Rodriguez-Romaguera, J., Sotres-Bayon, F., Mueller, D., & Quirk, G. J. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.01.009 · Cited by 119
Williams, D. T., MEHL, R., Yudofsky, S. C., ADAMS, D., & Roseman, B. (1982) · Journal of the American Academy of Child Psychiatry · doi:10.1016/s0002-7138(09)60911-0 · Cited by 117 · cited 1×
“Propranolol administered in 30–38 mg doses daily was found to significantly reduce uncontrollable rage outbursts in a study of 30 children and adolescents with organic brain dysfunction [110].”
BackgroundPropranolol in Chronic Anxiety Disorders: A Controlled Study
Kathol, R. G. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780250047005 · Cited by 115 · cited 1×
“After two weeks of treatment, propranolol severely decreased the physical aspects of anxiety, and it also significantly relieved other symptoms including shortness of breath, chest pains, and weakness that had some association to beta stimulation [88].”
BackgroundKindt, M., & van Emmerik, A. (2016) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125316644541 · Cited by 107 · cited 1×
“A case series found that providing 40 mg of propranolol shortly after reactivation decreased PTSD symptoms [79].”
BackgroundPharmacologic treatment approaches for children and adolescents with posttraumatic stress disorder
Donnelly, C. L. (2003) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/s1056-4993(02)00102-5 · Cited by 105
Anxiety and Performance in Sex, Sport, and Stage: Identifying Common Ground
Rowland, D. L., & van Lankveld, J. J. D. M. (2019) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.01615 · Cited by 105 · cited 1×
“Stage fright is a serious problem for many professional and amateur artists, as severe difficulties resulting from performance anxiety may lead to premature termination of promising careers [7,8].”
BackgroundThe amygdala encodes specific sensory features of an aversive reinforcer
Dębiec, J., Díaz-Mataix, L., Bush, D. E. A., Doyère, V., & LeDoux, J. E. (2010) · Nature Neuroscience · doi:10.1038/nn.2520 · Cited by 104 · cited 5×
“Furthermore, animal studies indicated that disrupting protein synthesis or blocking the β-AR after retrieval of a US reduced the expression of fear caused by numerous CSs [190,191].”
BackgroundInfluentialNoradrenergic blockade stabilizes prefrontal activity and enables fear extinction under stress
Fitzgerald, P. J., Giustino, T. F., Seemann, J. R., & Maren, S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1500682112 · Cited by 103
Olson, V. G., Rockett, H. R., Reh, R. K., Redila, V. A., Tran, P. M., Venkov, H. A., DeFino, M. C., Hague, C., Peskind, E. R., Szot, P., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.11.029 · Cited by 89 · cited 1×
“When given immediately after stress exposure [180], clonidine prevented stress-induced changes in behaviour, and it normalised such changes when given before behavioural testing [181].”
BackgroundNoradrenergic Regulation of Fear and Drug-Associated Memory Reconsolidation
Otis, J. M., Werner, C. T., & Mueller, D. T. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.243 · Cited by 89 · cited 1×
“This medicine crosses the blood–brain barrier and interferes with the neurobiological cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA)/cAMP response element binding protein (CREB) cascade that is involved in the reconsolidation of destabilised fear memories by acting on β-ARs in the AMG, a brain area cruci…”
BackgroundGeuze, E., Vermetten, E., de Kloet, C. S., Hijman, R., & Westenberg, H. G. M. (2009) · Depression and Anxiety · doi:10.1002/da.20476 · Cited by 87 · cited 1×
“Cognitive dysfunction has been identified in PTSD and linked to impaired traumatic memory processing [18], elevated psychiatric symptom severity, and functional disability [19].”
BackgroundClinical experiences with propranolol
Besterman, E. M. M., & Friedlander, D. H. (1965) · Postgraduate Medical Journal · doi:10.1136/pgmj.41.479.526 · Cited by 87
Pitman, R. K., Milad, M. R., Igoe, S. A., Vangel, M. G., Orr, S. P., Tsareva, A., Gamache, K., & Nader, K. (2011) · Behavioral Neuroscience · doi:10.1037/a0024364 · Cited by 85 · cited 1×
“Post-reactivation mifepristone may be a promising PTSD treatment, but not necessarily in combination with propranolol [185].”
BackgroundZoladz, P. R., Fleshner, M., & Diamond, D. M. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.01.001 · Cited by 81 · cited 1×
“Many of the behavioural and physiological characteristics elicited by the psychosocial stress model of PTSD were prevented by chronic clonidine administration (anxiety-related behaviour, enhanced startle reaction, tachycardia, and elevated BP) [179].”
BackgroundGamache, K., Pitman, R. K., & Nader, K. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.145 · Cited by 80 · cited 1×
“Clonidine has also been demonstrated to successfully block the reconsolidation of auditory fear memory [182], suggesting that it could be useful in reducing the strength of traumatic memories in PTSD patients.”
BackgroundAnxiety and post-traumatic stress symptoms following wisdom tooth removal
de Jongh, A., Olff, M., van Hoolwerff, H., Aartman, I. H. A., Broekman, B. F. P., Lindauer, R., & Boer, F. (2008) · Behaviour Research and Therapy · doi:10.1016/j.brat.2008.09.004 · Cited by 79
Brunet, A., Thomas, É., Saumier, D., Ashbaugh, A. R., Azzoug, A., Pitman, R. K., Orr, S. P., & Tremblay, J. (2014) · The Canadian Journal of Psychiatry · doi:10.1177/070674371405900408 · Cited by 72
Central β-adrenergic modulation of cognitive flexibility
Beversdorf, D. Q., White, D. M., Chever, D. C., Hughes, J. D., & Bornstein, R. A. (2002) · NeuroReport · doi:10.1097/00001756-200212200-00025 · Cited by 72
High Trait Anxiety: A Challenge for Disrupting Fear Memory Reconsolidation
Soeter, M., & Kindt, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075239 · Cited by 72 · cited 1×
“Regardless of participant body mass, 40 mg of propranolol was found to be an effective dose for fear neutralisation [100], and the medicine may be administered up to 1 h after reactivation [78].”
BackgroundThe Effect of Beta Blockade on Stress-Induced Cognitive Dysfunction in Adolescents
Faigel, H. C. (1991) · Clinical Pediatrics · doi:10.1177/000992289103000706 · Cited by 72 · cited 2×
“Furthermore, propranolol is useful in lowering emotional arousal [47], eradicating stage fright [48], and alleviating anxiety-related cognitive dysfunction [49].”
BackgroundSchwabe, L., Nader, K., & Pruessner, J. C. (2012) · Biological Psychology · doi:10.1016/j.biopsycho.2012.10.003 · Cited by 71 · cited 1×
“Furthermore, retrieval methods failed to reactivate the fear response [54,71,106].”
Effect of Propranolol on Functional Connectivity in Autism Spectrum Disorder—A Pilot Study
Narayanan, A., White, C. A., Saklayen, S., Scaduto, M. J., Carpenter, A. L., Abduljalil, A., Schmalbrock, P., & Beversdorf, D. Q. (2010) · Brain Imaging and Behavior · doi:10.1007/s11682-010-9098-8 · Cited by 69 · cited 10×
“Autism Spectrum Disorder (ASD) Propranolol may be beneficial to people who suffer from emotional, behavioural, and autonomic dysregulation (EBAD).”
BackgroundInfluentialHow Administration of the Beta-Blocker Propranolol Before Extinction can Prevent the Return of Fear
Kroes, M. C. W., Tona, K., den Ouden, H. E. M., Vogel, S., van Wingen, G. A., & Fernández, G. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.315 · Cited by 68 · cited 1×
“By decreasing retrieval of fear memories via the dorsal medial prefrontal cortex (dmPFC) and improving contextual safety learning via the HPC, beta-blockade can stop the recurrence of fear [137].”
BackgroundPrazosin for treatment of nightmares related to posttraumatic stress disorder
Taylor, H. R., Freeman, M. K., & Cates, M. E. (2008) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp070124 · Cited by 65
Pharmacologically induced amnesia for learned fear is time and sleep dependent
Kindt, M., & Soeter, M. (2018) · Nature Communications · doi:10.1038/s41467-018-03659-1 · Cited by 62
The effect of propranolol versus placebo on resident surgical performance.
(1998) · PubMed Central · Cited by 61
Propranolol Decreases Fear Expression by Modulating Fear Memory Traces
Santos, S. L., Stackmann, M., Zamora, A., Mastrodonato, A., Landri, A. V. D., Vaughan, N. D., Chen, B. K., Lanio, M., & Denny, C. A. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.01.005 · Cited by 60
PROPRANOLOL IN ORGANIC AGITATION
Petrie, W. M., & Ban, T. A. (1981) · The Lancet · doi:10.1016/s0140-6736(81)91930-9 · Cited by 59 · cited 1×
“The use of this medicine has been documented in case reports for the treatment of agitation in organic patients [125], aggressive behaviour following acute brain damage [126], and postencephalitic psychosis [127].”
BackgroundTypologies of posttraumatic stress disorder in the U.S. adult population
Pietrzak, R. H., El-Gabalawy, R. M., Tsai, J., Sareen, J., Neumeister, A., & Southwick, S. M. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.03.024 · Cited by 59 · cited 1×
“This disorder has been linked to an increase in the frequency of suicide behaviours, such as suicidal thoughts, plans, or actions, as well as other mood disorders and anxiety symptoms [23,24].”
BackgroundAlpha-2 receptor agonists for the treatment of posttraumatic stress disorder
Belkin, M., & Schwartz, T. (2015) · Drugs in Context · doi:10.7573/dic.212286 · Cited by 57 · cited 1×
“Clonidine has been shown to alleviate nightmares and hyperarousal symptoms in patients with PTSD [172,176,183,184].”
BackgroundZamzow, R., Ferguson, B. J., Stichter, J. P., Porges, E. C., Ragsdale, A. S., Lewis, M. L., & Beversdorf, D. Q. (2016) · Psychopharmacology · doi:10.1007/s00213-015-4199-0 · Cited by 56 · cited 1×
“In addition, increases in nonverbal communication [123] and reductions in hypersexual behaviours [124] were noted.”
BackgroundSagar-Ouriaghli, I., Lievesley, K., & Santosh, P. J. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118756245 · Cited by 56 · cited 3×
“Moreover, propranolol was found to be effective in reducing self-injurious behaviours (SIBs) in people with ASD [114].”
BackgroundA Clinical Approach to the Pharmacotherapy of Aggression in Children and Adolescents
Connor, D. F., & Steingard, R. J. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb32529.x · Cited by 54 · cited 1×
“A considerable reduction in aggression, organic brain dysfunction [108–110], and anxiety disorders [111,112] has been reported in adolescents with ASD [113].”
BackgroundNoradrenergic Moderation of Working Memory Impairments in Adults with Autism Spectrum Disorder
Bodner, K. E., Beversdorf, D. Q., Saklayen, S. S., & Christ, S. E. (2012) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617712000070 · Cited by 54 · cited 1×
“Individuals with ASD showed improvements in verbal problem solving [117,118], semantic processing [119], and working memory (WM) when administered propranolol [120].”
BackgroundTreatment of Post-Traumatic Stress Disorder Nightmares at a Veterans Affairs Medical Center
Detweiler, M., Pagadala, B., Candelario, J., Boyle, J., Detweiler, J., & Lutgens, B. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5120117 · Cited by 54
Use of propranolol to decrease aggressive outbursts in younger patients
Kuperman, S., & Stewart, M. A. (1987) · Psychosomatics · doi:10.1016/s0033-3182(87)72521-3 · Cited by 53 · cited 10×
“Autism Spectrum Disorder (ASD) Propranolol may be beneficial to people who suffer from emotional, behavioural, and autonomic dysregulation (EBAD).”
BackgroundInfluentialRoullet, P., Vaïva, G., Véry, E., Bourcier, A., Yrondi, A., Dupuch, L., Lamy, P., Thalamas, C., Jasse, L., El‐Hage, W., et al. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-00984-w · Cited by 53 · cited 4×
“They found no differences between propranolol and placebo on the severity of PTSD symptoms [66].”
BackgroundMethodInfluentialBENEFICIAL EFFECT OF BETA-ADRENERGIC BLOCKADE ON "EXAM. NERVES"
Brewer, C. L. (1972) · The Lancet · doi:10.1016/s0140-6736(72)91840-5 · Cited by 51
Diazepam, Propranolol and their Combination in the Management of Chronic Anxiety
Hallstrom, C., Treasaden, I., Edwards, J. G., & Lader, M. (1981) · British Journal of Psychiatry · doi:10.1192/bjp.139.5.417 · Cited by 48 · cited 1×
“[163] in a placebo-controlled crossover study with 24 patients.”
BackgroundElsey, J. W. B., Filmer, A. I., Galvin, H. R., Kurath, J., Vossoughi, L., Thomander, L. S., Zavodnik, M., & Kindt, M. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0857-z · Cited by 48 · cited 2×
“Administration of propranolol during reconsolidation mitigated public speaking anxiety [98].”
BackgroundEffect of propranolol on verbal problem solving in autism spectrum disorder
Beversdorf, D. Q., Carpenter, A. L., Miller, R. F., Cios, J. S., & Hillier, A. (2008) · Neurocase · doi:10.1080/13554790802368661 · Cited by 44 · cited 1×
“Individuals with ASD showed improvements in verbal problem solving [117,118], semantic processing [119], and working memory (WM) when administered propranolol [120].”
BackgroundNoradrenergic blockade and numeric working memory in humans
Müller, U., Mottweiler, E., & Bublak, P. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105048888 · Cited by 43 · cited 1×
“Furthermore, a reduction in diastolic BP was positively linked with a decrease in the severity of PTSD, confirming the anxiolytic effects of blockers via peripheral and central noradrenergic processes [138].”
BackgroundEffect of β‐blockers on platelet aggregation: a systematic review and meta‐analysis
Bonten, T. N., Plaizier, C. E. I., Snoep, J. D., Stijnen, T., Dekkers, O. M., & van der Bom, J. G. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12404 · Cited by 42 · cited 1×
“, in a meta-analysis including 31 studies, found that propranolol significantly decreased platelet aggregation [44].”
BackgroundAudi, E. A., de Oliveira, R. M. W., & Graeff, F. G. (1991) · Psychopharmacology · doi:10.1007/bf02244379 · Cited by 42 · cited 1×
“Furthermore, propranolol injections into the dorsal periaqueductal grey (DPAG) have an anxiolytic effect because they increase the release of 5-HT, acting on post-synaptic 5-HT2 receptors, resultant from blockade of 5-HT1B autoreceptors that inhibit amine release from serotonergic nerve endings [136].”
BackgroundAlao, A. O., Selvarajah, J., & Razi, S. (2012) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.44.2.g · Cited by 42 · cited 1×
“Clonidine has been shown to alleviate nightmares and hyperarousal symptoms in patients with PTSD [172,176,183,184].”
BackgroundMahabir, M., Tucholka, A., Shin, L. M., Etienne, P. E., & Brunet, A. (2015) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2015.10.004 · Cited by 42
Krauseneck, T., Padberg, F., Roozendaal, B., Grathwohl, M., Weis, F., Hauer, D., Kaufmann, I., Schmoeckel, M., & Schelling, G. (2010) · Psychological Medicine · doi:10.1017/s0033291709990614 · Cited by 40
Rosenberg, L., Rosenberg, M., Sharp, S., THOMAS, C. R., Humphries, H. F., Holzer, C. E., Herndon, D. N., & Meyer, W. J. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2017.0073 · Cited by 40 · cited 1×
“Children with PTSD often exhibit avoidance behaviours, increased arousal, flashbacks, and nightmares [27].”
BackgroundChowdhury, D., Bansal, L., Duggal, A. K., Datta, D., Mundra, A., Krishnan, A., Koul, A., & Gupta, A. (2021) · Cephalalgia · doi:10.1177/03331024211047454 · Cited by 40 · cited 1×
“Other than those described above, therapeutic applications of propranolol include, but are not limited to, migraine prophylaxis [129], cluster headache prevention [130], and pheochromocytoma [131].”
BackgroundThe effect of acute beta‐adrenoceptor blockade on examination performance.
Drew, P., Barnes, J., & Evans, S. (1985) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1985.tb02714.x · Cited by 40
Effect of Propranolol on Word Fluency in Autism
Beversdorf, D. Q., Saklayen, S. S., Higgins, K. F., Bodner, K. E., Kanne, S. M., & Christ, S. E. (2011) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0b013e318204d20e · Cited by 39 · cited 1×
“Individuals with ASD showed improvements in verbal problem solving [117,118], semantic processing [119], and working memory (WM) when administered propranolol [120].”
BackgroundAcute but Not Permanent Effects of Propranolol on Fear Memory Expression in Humans
Chalkia, A., Weermeijer, J. D. M., Oudenhove, L. V., & Beckers, T. (2019) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2019.00051 · Cited by 39 · cited 2×
“It has been demonstrated that propranolol has an acute effect on fear-potentiated startle responses [89].”
BackgroundHao, Y., Jing, H., Bi, Q., Zhang, J., Qin, L., & Yang, P. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.08.052 · Cited by 38 · cited 1×
“Other research has connected NE (and propranolol) with IL-6 signalling, and one group suggested that infusion of the inflammatory cytokine IL-6 into the basolateral amygdala (BLA) in rats may alter fear extinction learning, possibly through the JAK/STAT3 pathway [140,141].”
BackgroundGoldstein, S. (1983) · PubMed · Cited by 37
Aykaç, A., Aydın, B., Cabadak, H., & Gören, M. Z. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.04.002 · Cited by 36
Psychological Impact of Third Molar Surgery: A 1-Month Prospective Study
de Jongh, A., van Wijk, A. J., & Lindeboom, J. A. H. (2010) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2010.05.073 · Cited by 36
Current and Future Status of Beta‐blockers in the Treatment of Hypertension
Chrysant, S. G., Chrysant, G. S., & Dimas, B. (2008) · Clinical Cardiology · doi:10.1002/clc.20249 · Cited by 33 · cited 1×
“Propranolol has also been extensively used for the management of essential hypertension [45].”
BackgroundA comparison of propranolol and diazepam for preoperative anxiolysis
Dyck, J. B., & Chung, F. F. (1991) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/bf03008446 · Cited by 33 · cited 1×
“Additionally, studies on propranolol have indicated that it can alleviate less stressful conditions such as exam anxiety [90–92], stage fright [48], performance anxiety in musicians [93], and fear of surgery [94,95].”
BackgroundHegarty, J. P., Ferguson, B. J., Zamzow, R., Rohowetz, L. J., Johnson, J. D., Christ, S. E., & Beversdorf, D. Q. (2016) · Brain Imaging and Behavior · doi:10.1007/s11682-016-9604-8 · Cited by 33 · cited 10×
“Autism Spectrum Disorder (ASD) Propranolol may be beneficial to people who suffer from emotional, behavioural, and autonomic dysregulation (EBAD).”
BackgroundInfluentialZamzow, R., Ferguson, B. J., Ragsdale, A. S., Lewis, M. L., & Beversdorf, D. Q. (2016) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2016.1252724 · Cited by 33 · cited 1×
“Individuals with ASD showed improvements in verbal problem solving [117,118], semantic processing [119], and working memory (WM) when administered propranolol [120].”
BackgroundBarton, A., Moffett, B. S., Valdés, S. O., Miyake, C. Y., & Kim, J. J. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.08.067 · Cited by 32 · cited 1×
“assessed the efficacy and safety of high-dose propranolol for the management of supraventricular tachyarrhythmias (SVTs) in infants (N = 287) [43].”
BackgroundVetere, G., Piserchia, V., Borreca, A., Novembre, G., Aceti, M., & Ammassari‐Teule, M. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00211 · Cited by 32
File, S. E., & Lister, R. (1985) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1985.tb02669.x · Cited by 31 · cited 1×
“In another study, File and Lister [162] compared the effects of lorazepam with propranolol on experimentally-induced performance anxiety in a double-blind crossover study.”
BackgroundPROPRANOLOL INCREASES REDUCED BETA-RECEPTOR FUNCTION IN SEVERELY ANXIOUS PATIENTS
Lima, D., & Turner, P. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90855-3 · Cited by 31 · cited 1×
“Many of the symptoms of performance anxiety, including tremor and palpitations, are brought on by an increase in the release of adrenaline and NE from the sympathetic nervous system and adrenal medulla, and medications that block beta-adrenoceptors, such as propranolol, minimise or eliminate these symptoms [135].”
BackgroundBeta-Adrenergic Blockade and Voice: A Double-Blind, Placebo-Controlled Trial
Giddens, C. L., Barron, K. W., Clark, K. F., & Warde, W. D. (2009) · Journal of Voice · doi:10.1016/j.jvoice.2008.12.002 · Cited by 30 · cited 1×
“, 2010 [158] Double-blind, placebo controlled 12 adults, 6 male and 6 female, between the ages of 20 and 29 years Each participant was given either 40 mg propranolol or placebo, as dictated by the randomisation schedule, with a glass of water.”
MethodThe Role of Propranolol as a Repurposed Drug in Rare Vascular Diseases
Cuesta, Á. M., Gallardo‐Vara, E., Casado‐Vela, J., Recio-Poveda, L., Botella, L. M., & Albiñana, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084217 · Cited by 30 · cited 1×
“Propranolol has been also used in the treatment of various rare vascular diseases, including hereditary haemorrhagic telangiectasia, von Hippel– Lindau disease, paraganglioma syndrome, cerebral cavernous malformations, angiosarcoma, and tuberous sclerosis [132].”
BackgroundAnanth, J., & Lin, K. (2008) · Neuropsychobiology · doi:10.1159/000118236 · Cited by 29
Use of Propranolol for Hypersexual Behavior in an Adolescent With Autism
Deepmala, & Agrawal, M. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014541630 · Cited by 29 · cited 2×
“In addition, increases in nonverbal communication [123] and reductions in hypersexual behaviours [124] were noted.”
BackgroundUse of propranolol in the treatment of postencephalitic psychosis
Schreier, H. A. (1979) · American Journal of Psychiatry · doi:10.1176/ajp.136.6.840 · Cited by 29
Anxiety and β-Adrenergic Blockade
Stone, W. N. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.04200050033005 · Cited by 28
Effect of a Beta-adrenergic Blocking Agent on Dental Anxiety
Liu, H. H., Milgrom, P., & Fiset, L. O. (1991) · Journal of Dental Research · doi:10.1177/00220345910700091401 · Cited by 28 · cited 2×
“It has been observed that, as compared to placebo, 80 to 120 mg of oral propranolol significantly reduced self-reported states of anxiety during injection of a local dental anaesthetic [101].”
BackgroundZhou, J., Luo, Y., Zhang, J., Li, M., Wang, C., Guan, X., Wu, P., Hu, Z., Jin, Y., Ni, L., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13272 · Cited by 28 · cited 1×
“By altering the stability of GluA1 in LA, propranolol successfully prevented the changes brought on by NE and reactivation [151].”
BackgroundHuang, B. Y., Zhu, H., Zhou, Y., Liu, X., & Ma, L. (2017) · Frontiers in Neural Circuits · doi:10.3389/fncir.2017.00053 · Cited by 28 · cited 5×
“Furthermore, animal studies indicated that disrupting protein synthesis or blocking the β-AR after retrieval of a US reduced the expression of fear caused by numerous CSs [190,191].”
BackgroundInfluentialLaser treatment of primary axillary hyperhidrosis: a review of the literature
Cervantes, J., Perper, M., Eber, A. E., Fertig, R. M., Tsatalis, J. P., & Nouri, K. (2018) · Lasers in Medical Science · doi:10.1007/s10103-017-2434-0 · Cited by 28 · cited 1×
“Oral propranolol administration seems to be an effective method to minimise the development of sight-threatening choroidal effusion after glaucoma surgery [133] as well as an effective and safe medication in the treatment of primary hyperhidrosis [134].”
A Preliminary Investigation on the Effects of Atenolol for Treating Symptoms of Anxiety
Armstrong, C., & Kapolowicz, M. R. (2020) · Military Medicine · doi:10.1093/milmed/usaa170 · Cited by 28 · cited 1×
“Compared with propranolol, the main benefit is higher propranolol tolerance, but the drawback is that there are no randomised clinical trials on this topic yet [170].”
BackgroundFani, N., Kitayama, N., Ashraf, A., Reed, L., Afzal, N., Jawed, F., & Bremner, J. D. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4094 · Cited by 27 · cited 1×
“[168], paroxetine enhanced verbal declarative memory in PTSD patients, however, this improvement was not statistically different from placebo.”
BackgroundTawa, J., & Murphy, S. (2013) · Journal of the American Association of Nurse Practitioners · doi:10.1111/1745-7599.12016 · Cited by 25
Propranolol's impact on cognitive performance in post-traumatic stress disorder
Mahabir, M., Ashbaugh, A. R., Saumier, D., & Tremblay, J. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.11.051 · Cited by 25 · cited 5×
“Moreover, propranolol may alter visuospatial processes associated with the resolution of traumatic intrusions in those with chronic PTSD [53].”
BackgroundInfluentialTran, K. T., Moulton, K., Santesso, N. A., & Rabb, D. (2016) · Europe PMC (PubMed Central) · Cited by 25
Morissette, S. B., Spiegel, D. A., & Barlow, D. H. (2007) · Journal of Psychopathology and Behavioral Assessment · doi:10.1007/s10862-007-9061-1 · Cited by 22 · cited 1×
“In patients with SAD, propranolol was combined with one session of exposure [97].”
BackgroundPediatric Antipsychotic Use and Outcomes Monitoring
Santosh, P., Bell, L., Fiori, F., & Singh, J. (2016) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2015.0247 · Cited by 22 · cited 1×
“Propranolol’s anxiolytic impact via the autonomic nervous system may be beneficial in people with greater physiological anxiety [116].”
BackgroundDeng, J., Shi, L., Yuan, K., Yao, P., Chen, S., Que, J., Gong, Y.-M., Bao, Y., Shi, J., Han, Y., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-01023-w · Cited by 21 · cited 6×
“Furthermore, animal studies indicated that disrupting protein synthesis or blocking the β-AR after retrieval of a US reduced the expression of fear caused by numerous CSs [190,191].”
BackgroundInfluentialPresence, Content, and Characteristics of Memories of Individuals with Dental Phobia
van Houtem, C. M. H. H., van Wijk, A. J., & de Jongh, A. (2015) · Applied Cognitive Psychology · doi:10.1002/acp.3127 · Cited by 20
Young, R., & Glennon, R. A. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1317-2 · Cited by 20
Thierrée, S., Richa, S., Brunet, A., Egreteau, L., Roig, Q., Clarys, D., & El‐Hage, W. (2020) · European Journal of Psychotraumatology · doi:10.1080/20008198.2020.1733248 · Cited by 19 · cited 1×
“Propranolol therapy seems to be a potentially safe and effective therapeutic option for children with PTSD symptoms [80].”
BackgroundCurrent concepts in clinical therapeutics: anxiety disorders, Part 1.
Cs, D., & Hayes, P. E. (1987) · PubMed · Cited by 18
Protective effect of propranolol and nadolol on social defeat-induced behavioral impairments in rats
Zaidi, S., Atrooz, F., Valdez, D., Liu, H., Kochi, C., Bond, R. A., & Salim, S. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.134892 · Cited by 18 · cited 2×
“In rats, propranolol and nadolol treatment mitigated SD-induced depression-like behaviour as well as social interaction, suggesting that β2-ARs may play a role in mediating the anxiety response [192].”
BackgroundPlacebo and Non-specific Effects in Reconsolidation-Based Treatment for Arachnophobia
Elsey, J. W. B., & Kindt, M. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.775770 · Cited by 18 · cited 3×
“They discovered a trend for better results in the placebo group, who showed larger improvement in phobic behaviour scores than the propranolol group [107].”
MethodResultInfluentialKaushik, S., Kataria, P., Joshi, G., Singh, R., Handa, S., Pandav, S. S., Ram, J., & Gupta, A. (2019) · Ophthalmology Glaucoma · doi:10.1016/j.ogla.2019.03.006 · Cited by 17
Shinba, T., Shinozaki, T., & Mugishima, G. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00203-2 · Cited by 16 · cited 1×
“When given immediately after stress exposure [180], clonidine prevented stress-induced changes in behaviour, and it normalised such changes when given before behavioural testing [181].”
BackgroundGardner, A. J., & Griffiths, J. (2014) · Critical Care · doi:10.1186/s13054-014-0698-3 · Cited by 16 · cited 2×
“The ability of the hippocampus (HPC, the main location for memory storage) to control the memory of traumatic events is also found to be dysfunctional [20].”
BackgroundRobinson, S., Christ, C. C., Cahill, M. M., Aldrich, S. J., & Taylor-Yeremeeva, E. M. (2018) · Physiology & Behavior · doi:10.1016/j.physbeh.2018.10.012 · Cited by 16 · cited 2×
“Propranolol can help with stress-related symptoms via affecting AMG-dependent memory reconsolidation and peripheral noradrenergic signalling [51].”
BackgroundMihai, R., Sadler, G. P., & Bridge, H. (2007) · European Journal of Anaesthesiology · doi:10.1017/s0265021507002955 · Cited by 15 · cited 1×
“Other than those described above, therapeutic applications of propranolol include, but are not limited to, migraine prophylaxis [129], cluster headache prevention [130], and pheochromocytoma [131].”
BackgroundSweeney, D. P., Forness, S. R., & Levitt, J. G. (1998) · Focus on Autism and Other Developmental Disabilities · doi:10.1177/108835769801300302 · Cited by 15 · cited 1×
“A considerable reduction in aggression, organic brain dysfunction [108–110], and anxiety disorders [111,112] has been reported in adolescents with ASD [113].”
BackgroundThe effect of beta blockade on stage fright. A controlled study.
Brantigan, C. O., Ta, B., & Joseph, N. (1979) · PubMed · Cited by 15
Burhans, L. B., Smith‐Bell, C. A., & Schreurs, B. G. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.03.029 · Cited by 15
Beta-blocker heart attack trial: Impact of propranolol therapy on ventricular arrhythmias
Morganroth, J., Lichstein, E., & Byington, R. P. (1985) · Preventive Medicine · doi:10.1016/0091-7435(85)90061-1 · Cited by 14
Siblings of children with tracheoesophageal dysrhaphism.
Baird, P. A., & MacDonald, E. C. (1981) · PubMed · Cited by 12
Lee, S., Yoon, S.-B., Cho, J.-R., Choi, S., Jung, J.-H., & Lee, N. (2008) · Angiology · doi:10.1177/0003319708315303 · Cited by 11 · cited 1×
“For example, propranolol has been found to be as effective as carvedilol on left ventricular volume and function after primary coronary stenting in acute myocardial infarction [42].”
BackgroundPharmacological treatment of extreme self-injurious behavior in autism
Knabe, R., & BOVIER, P. A. (1992) · European Psychiatry · doi:10.1017/s0924933800002194 · Cited by 11 · cited 10×
“Autism Spectrum Disorder (ASD) Propranolol may be beneficial to people who suffer from emotional, behavioural, and autonomic dysregulation (EBAD).”
BackgroundInfluentialPropranolol in Experimentally Induced Stress
Taylor, E., Turner, P., & Harrison, J. (1981) · The British Journal of Psychiatry · doi:10.1192/bjp.139.6.545 · Cited by 9 · cited 1×
“Additionally, propranolol markedly reduced the skin’s temperature increase on the trunk [52].”
BackgroundOral premedication one hour before minor gynaecological surgery — does it have any effect?
Jakobsson, J., Rane, K., & Ryberg, G. (1995) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.1995.tb04078.x · Cited by 9 · cited 1×
“Additionally, studies on propranolol have indicated that it can alleviate less stressful conditions such as exam anxiety [90–92], stage fright [48], performance anxiety in musicians [93], and fear of surgery [94,95].”
BackgroundTreatment of Anxiety Prior to a Medical Procedure using an Atenolol - Scopolamine Combination Drug
Thomas, T., & Dooley, T. P. (2018) · Journal of Depression & Anxiety · doi:10.4172/2167-1044.1000303 · Cited by 8
Influence of CGP 361A, propranolol and diazepam on autonomous reactions to different stressors
Albus, M., Zellmer, A., Bondy, B., Müller-Spahn, F., Engel, R. R., & Ackenheil, M. (1989) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(89)90006-7 · Cited by 7 · cited 1×
“[161] studied the autonomous reactions to different stressors and found that propranolol (40 mg) was more effective than diazepam (10 mg) and isamoltane (4 mg) in reducing excessive HR, elevated plasma NE levels, and BP.”
BackgroundSteenen, S. A., van Wijk, A. J., van Westrhenen, R., de Lange, J., & de Jongh, A. (2015) · Trials · doi:10.1186/s13063-015-1065-7 · Cited by 7 · cited 2×
“Furthermore, propranolol has the capacity to inhibit ‘memory reconsolidation’ (that is, it blocks the process of storing a recently retrieved fear memory) [102].”
BackgroundIbrahim, A. N., & Atallah, R. Y. (2016) · Egyptian Journal of Anaesthesia · doi:10.1016/j.egja.2016.08.020 · Cited by 7 · cited 1×
“Ibrahim and Atallah [165] conducted a comparative prospective double blind randomised study to test ivabradine versus propranolol given orally in microlaryngoscopic surgeries for attenuating stress response.”
BackgroundUsing Beta-blockers to Control Stage Fright: A Dancer’s Dilemma
Harris, D. A. (2001) · Medical Problems of Performing Artists · doi:10.21091/mppa.2001.2012 · Cited by 7
Schmidt, J., Dombovy, M. L., & Watkins, K. (1995) · Neurorehabilitation and neural repair · doi:10.1177/154596839500900106 · Cited by 5
Propranolol and cluster headache.
Fogelholm, R. (1972) · BMJ · doi:10.1136/bmj.4.5832.110-a · Cited by 4
Resolution of flashbacks of PTSD with propranolol: A case report
Chandavarkar, R., Sangha, S., & Khalil, S. (2016) · Progress in Neurology and Psychiatry · doi:10.1002/pnp.418 · Cited by 1 · cited 6×
“The use of propranolol to mask the physical symptoms of anxiety is well established [29].”
BackgroundInfluentialPropranolol versus Metoprolol in Anxiety Disorders
Chaturvedi, S. K. (1987) · The Canadian Journal of Psychiatry · doi:10.1177/070674378703200327 · Cited by 1 · cited 1×
“For example, Chaturvedi [164] showed that metoprolol, a selective β1 adrenoceptor antagonist, has been found to reduce anxiety symptoms more effectively and also seems to have fewer side effects as compared to propranolol.”
BackgroundPropranolol Inhibits Reactivation of Fear Memory
Pennington, Z. T., & Cai, D. J. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.04.007 · Cited by 1 · cited 2×
“Despite propranolol’s ability to block access to the fear memory engram in the HPC during memory retrieval, it is probable that decreased activity in the ILA reduced extinction learning [22].”
Background
Research works printed but not linked: 2
- Barlow, D.H. (2002). Anxiety and Its Disorders: The Nature and Treatment of Anxiety and Panic, Guilford Press. [2nd ed.].
- 1981, The treatment of acute postpartum psychosis, Can. Med. Assoc. J., 125, 1083
Cited by
Beta-blockers in cardiac arrhythmias–Clinical pharmacologist’s point of view
Wołowiec, Ł., Grześk, G., Osiak, J., Wijata, A., Mędlewska, M., Gaborek, P., Banach, J., Wołowiec, A., & Głowacka, M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1043714 · Cited by 58
“Moreover, another meta-analysis also showed a lack of evidence of satisfactory quality to determine, whether or not to use propranolol in the treatment of stage fright (Szeleszczuk and Frączkowski, 2022).”
BackgroundBeta-blockers for the treatment of anxiety disorders: A systematic review and meta-analysis
Archer, C., Wiles, N., Kessler, D. A., Turner, K. M., & Caldwell, D. M. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.09.068 · Cited by 40
Network Meta-analysis of Different Treatments for Vestibular Migraine
Chen, J.-J., Zeng, B., Su, K., Wu, Y., Tu, Y., Stubbs, B., Chen, T., Zeng, B., Chen, Y., Hsu, C., et al. (2023) · CNS Drugs · doi:10.1007/s40263-023-01037-0 · Cited by 27
“Propranolol, which can cross the blood–brain barrier, acts not only on the β-adrenergic receptor but also weakly on certain serotonin receptors, such as 5-HT1A, 5-HT1B, and 5-HT2B [59], thus exerting anxiolytic effects [59].”
BackgroundDepression and anxiety management in cirrhosis
Zimbrean, P. C., & Jakab, S. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000600 · Cited by 24
Li, H., Cheng, H., Ding, K., Zhang, Y., Gao, F., Zhu, G., & Zhang, Z. (2024) · European Journal of Neuroscience · doi:10.1111/ejn.16445 · Cited by 14
“Propranolol acts on brain areas critical for learning and memory, including the hippocampus, PFC, and dorsal dentate gyrus (Szeleszczuk & Fraczkowski, 2022).”
Metadata
- Authors
- Szeleszczuk, Ł., & Frączkowski, D.
- Affiliations
- Medical University of Warsaw (PL)
- Corresponding author
- Szeleszczuk, Łukasz
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-09-03
- Volume
- 23
- Issue
- 17
- Pages
- 10099
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC9456064
- OpenAlex
- W4294733063
- Cited by
- 46
- References
- 195
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 13 · 2023: 5 · 2022: 1
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Keywords
- propranolol, stage fright, post-traumatic stress disorder, anxiety, stress, off-label drug use, beta-blockers, adrenergic receptors, blood-brain barrier, mechanism of action, drug comparison
- MeSH terms
- Anxiety, Anxiety Disorders, Humans, Propranolol, Stress Disorders, Post-Traumatic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.


